Sheila Shaigany
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $2,500 | 1 | 68.0% |
| Unspecified | $950.00 | 1 | 25.8% |
| Food and Beverage | $227.45 | 2 | 6.2% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $2,609 | 2 | $0 (2024) |
| ONQUALITY PHARMACEUTICALS (USA) LLC | $950.00 | 1 | $0 (2022) |
| Janssen Biotech, Inc. | $118.00 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $109.45 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($109.45) |
| 2023 | $2,500 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($2,500) |
| 2022 | $1,068 | 2 | ONQUALITY PHARMACEUTICALS (USA) LLC ($950.00) |
All Payment Transactions
4 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $109.45 | General |
| Category: IMMUNOLOGY | ||||||
| 11/27/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| Category: IMMUNOLOGY | ||||||
| 09/11/2022 | ONQUALITY PHARMACEUTICALS (USA) LLC | — | — | Cash or cash equivalent | $950.00 | Research |
| Study: Unpublished research | ||||||
| 03/26/2022 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $118.00 | General |
| Category: Immunology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Unpublished research | ONQUALITY PHARMACEUTICALS (USA) LLC | $950.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 968 | 2,544 | $737,198 | $117,828 |
| 2022 | 15 | 888 | 1,276 | $643,087 | $109,745 |
| 2021 | 12 | 678 | 850 | $429,410 | $87,346 |
| 2020 | 8 | 226 | 260 | $123,450 | $24,085 |
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 192 | 305 | $210,145 | $33,590 | 16.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 93 | 97 | $85,263 | $15,115 | 17.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 128 | 176 | $86,944 | $13,769 | 15.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 73 | 73 | $66,941 | $10,681 | 16.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 71 | 86 | $46,784 | $7,680 | 16.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 43 | 67 | $30,820 | $7,327 | 23.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 90 | 132 | $45,672 | $6,510 | 14.3% |
| 95044 | Test for allergy using skin patch | Office | 2023 | 13 | 1,040 | $46,800 | $5,368 | 11.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 42 | 45 | $28,845 | $4,695 | 16.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 48 | 48 | $29,856 | $4,627 | 15.5% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 20 | 20 | $13,660 | $2,349 | 17.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 65 | 344 | $13,072 | $2,139 | 16.4% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 27 | 33 | $9,669 | $1,604 | 16.6% |
| 11104 | Punch biopsy, first skin growth | Facility | 2023 | 16 | 16 | $10,928 | $710.74 | 6.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 13 | 13 | $4,069 | $693.81 | 17.1% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 11 | 13 | $3,224 | $633.78 | 19.7% |
| 11105 | Punch biopsy, each additional skin growth | Facility | 2023 | 11 | 13 | $4,368 | $318.18 | 7.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 12 | 23 | $138.00 | $19.35 | 14.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 152 | 261 | $179,829 | $30,371 | 16.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 103 | 107 | $94,053 | $19,583 | 20.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 116 | 151 | $74,594 | $12,089 | 16.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 82 | 82 | $75,194 | $11,748 | 15.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 62 | 62 | $38,564 | $6,333 | 16.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 54 | 62 | $33,728 | $5,815 | 17.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 48 | 54 | $34,614 | $5,522 | 16.0% |
About Sheila Shaigany
Sheila Shaigany is a Student in an Organized Health Care Education/Training Program healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/07/2016. The National Provider Identifier (NPI) number assigned to this provider is 1295184596.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sheila Shaigany has received a total of $3,677 in payments from pharmaceutical and medical device companies, with $109.45 received in 2024. These payments were reported across 4 transactions from 3 companies. The most common payment nature is "Consulting Fee" ($2,500).
As a Medicare-enrolled provider, Shaigany has provided services to 2,760 Medicare beneficiaries, totaling 4,930 services with total Medicare billing of $339,004. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Dermatology
- Location New York, NY
- Active Since 06/07/2016
- Last Updated 03/14/2022
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1295184596
Products in Payments
- SPEVIGO (Drug) $2,609
- TREMFYA (Drug) $118.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in New York
Dr. Saakshi Khattri, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $1.7M
Cheguevara Afaneh, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $1.5M
John Allan, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $550,557
Jose Scher, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $496,980
Dr. Anthony Rossi, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $442,377
Anuradha Lala-Trindade
Student in an Organized Health Care Education/Training Program — Payments: $284,341